Back to Atlas

Microsoft Dragon Copilot

Microsoft

Captures clinical conversations and produces draft documentation and workflow outputs for clinician review.

Designed for

Clinician

Care setting

Ambulatory and hospital care

Specialty

Multispecialty

Public evidence assessedReviewed August 31, 2026

Bottom line

The public evidence provides credible support for documentation-efficiency and clinician-experience benefits. It is less conclusive about the clinical accuracy of the current Dragon Copilot version, especially rare serious errors, omissions, and downstream record effects.

Based on public sources. RIR did not independently test this product. This is not an endorsement or recommendation.

What the evidence supports

Reviewed official materials establish a marketed ambient documentation workflow that produces drafts for clinician review.

What remains uncertain

Independent comparisons of omission rates, subgroup performance, and behavior after model updates remain limited in the represented sources.

How it was studied

Dragon Ambient eXperience, the predecessor to Dragon Copilot, has been studied through pre-post implementations, clinician surveys, and a pragmatic randomized trial. The randomized trial assigned 238 outpatient physicians across 14 specialties to DAX Copilot, Nabla, or usual care and used change in EHR note-writing time as the primary outcome.

Intended use
Support clinical documentation and related workflow tasks while keeping the clinician responsible for reviewing and finalizing outputs.
Represented version
Public product materials accessed August 2026; software version not specified
Regulatory context
Regulatory classification was not independently determined from the reviewed public materials.
For clinical and investment reviewEvidence context and questions for deeper review

Evidence source base

Published health-system studies and product documentation. Product version continuity between DAX Copilot and the current Dragon Copilot configuration requires confirmation.

Important limitation

The available studies address documentation burden and clinician experience more directly than rare, clinically consequential note errors or downstream effects on orders, coding, and the longitudinal record.

Questions to ask

  1. 01How are clinically material omissions measured?
  2. 02Which product changes trigger revalidation?
  3. 03How are clinician corrections monitored?